4.2 Article

A novel application for a 3-dimensional timelapse assay that distinguishes chemotactic from chemokinetic responses of hematopoietic CD133 + stem/progenitor cells

Journal

STEM CELL RESEARCH
Volume 11, Issue 2, Pages 707-720

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.scr.2013.04.006

Keywords

-

Funding

  1. NHS Blood and Transplant
  2. Technology Strategy Board
  3. National Institutes of Health Research
  4. National Institutes for Health Research (NIHR) [RP-PG-0310-1003]
  5. National Institute for Health Research [RP-PG-0310-1003] Funding Source: researchfish
  6. National Institutes of Health Research (NIHR) [RP-PG-0310-1003] Funding Source: National Institutes of Health Research (NIHR)

Ask authors/readers for more resources

Efficient homing/mobilization of human hematopoietic stem/progenitor cells to/from bone marrow niches enhances their therapeutic efficacy. Additionally, homing is dependent on cell source and may be modulated by prior ex vivo cell expansion. Here, we describe a novel application of a 3-dimensional time-lapse method for assessing trafficking of individual human cord blood CD133(+) hematopoietic stem/progenitor cells in vitro, using the key chemokine CXCL12 as a paradigm. This new methodology allows distinction between chemotactic responses (displacementvof center of mass and the forward migration index of the cells), and chemokinetic responses such as total cell path traveled in any direction (accumulated distance) and cell velocity in a 3-dimensional matrix. Other key advantages of this novel assay over existing assays include the ability to assess individual cell migration over times comparable to in vivo homing and rapid mobilization assays (18-24 h) and to directly compare the strength or response of individual hematopoietic progenitor cells to different or competing stimuli and small molecule inhibitors in a single assay prior to analyses in vivo. Importantly, using this method, our results demonstrate definitively that CXCL12 regulates the chemotactic responses of human cord blood CD133(+) cells, but not their random migration or chemokinesis. Crown Copyright (C) 2013 Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available